Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05553912 · ClinicalTrials.gov registry record · NA
QBSafe: a Randomized Trial of a Novel Intervention to Improve Care for People Living With Type 2 Diabetes.
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 143
- Enrollment target
NCT05553912 is a NA study that has completed, run by Yale University. The registered enrollment target is 143 participants.
The verdict
NCT05553912, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 143 participants
- Enrollment target
Study Summary
Glycemic control is often the main indicator of successful diabetes care, but a singular focus on glycemic control may lead to patients' overall health and wellbeing being overlooked or undervalued. The investigators have previously developed an intervention comprised of (a) a set of conversation cards designed to enable patients to identify aspects of life with diabetes important to them and to share them with their clinician to obtain their input; and (b) materials that help clinicians respond to patient concerns. The investigators will now conduct a randomized clinical trial to test the feasibility of the research procedures and efficacy of the intervention with respect to patient reported outcome measures.
Interventions
- BEHAVIORAL QBSafe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2022-11-02 |
| Est. Completion | 2025-02-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05553912
The ClinicalTrials.gov registry entry for NCT05553912 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which QBSafe is the first listed.
NCT05553912 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05553912 about?
NCT05553912 is a clinical study titled "QBSafe: a Randomized Trial of a Novel Intervention to Improve Care for People Living With Type 2 Diabetes.". Glycemic control is often the main indicator of successful diabetes care, but a singular focus on glycemic control may lead to patients' overall health and wellbeing being overlooked or undervalued. The investigators have previously developed an intervention comprised of (a) a set of conversation ca...
What is the current status of trial NCT05553912?
This trial is currently completed. It is a NA study. The enrollment target is 143 participants. The study started on 2022-11-02. Estimated completion is 2025-02-24.
What interventions are being tested in trial NCT05553912?
The interventions under investigation include: QBSafe (BEHAVIORAL).
Who is sponsoring clinical trial NCT05553912?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.